<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7807270</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22115</journal-id>
<journal-id journal-id-type="nlm-ta">Environ Int</journal-id>
<journal-id journal-id-type="iso-abbrev">Environ Int</journal-id>
<journal-title-group>
<journal-title>Environment international</journal-title>
</journal-title-group>
<issn pub-type="ppub">0160-4120</issn>
<issn pub-type="epub">1873-6750</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30278311</article-id>
<article-id pub-id-type="pmc">6712572</article-id>
<article-id pub-id-type="doi">10.1016/j.envint.2018.09.025</article-id>
<article-id pub-id-type="manuscript">NIHMS1508557</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Environmental styrene exposure and neurologic symptoms in U.S. Gulf coast residents</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Werder</surname>
<given-names>Emily J</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Engel</surname>
<given-names>Lawrence S</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Richardson</surname>
<given-names>David B</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Emch</surname>
<given-names>Michael E</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gerr</surname>
<given-names>Fredric E</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kwok</surname>
<given-names>Richard K</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sandler</surname>
<given-names>Dale P</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina</aff>
<aff id="A2"><label>2</label>Epidemiology Department, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina</aff>
<aff id="A3"><label>3</label>Department of Occupational and Environmental Health, University of Iowa College of Public Health, Iowa City, Iowa</aff>
<author-notes>
<corresp id="CR1">Corresponding Author: Dale P. Sandler, PhD, Epidemiology Branch, National Institute of Environmental Health Sciences, P.O. Box 12233, Mail Drop A3-05, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709-2233, Ph: 919-541-4668, Fax: 301-480-3290, <email>sandler@niehs.nih.gov</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P59">The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>121</volume>
<issue>Pt 1</issue>
<fpage>480</fpage>
<lpage>490</lpage>
<!--elocation-id from pubmed: 10.1016/j.envint.2018.09.025-->
<abstract id="ABS1">
<sec id="S1">
<title>Background:</title>
<p id="P1">Styrene is an established neurotoxicant at occupational levels, but effects at levels relevant to the general population have not been studied. We examined the neurologic effects of environmental styrene exposure among U.S. Gulf coast residents.</p>
</sec>
<sec id="S2">
<title>Methods:</title>
<p id="P2">We used National Air Toxics Assessment 2011 estimates of ambient styrene concentrations to assign exposure levels for 21,962 non-diabetic Gulf state residents, and additionally measured blood styrene concentration in a subset of participants (n=874). Neurologic symptoms, as well as detailed covariate information, were ascertained via telephone interview. We used log-binomial regression to estimate prevalence ratios (PR) and 95% confidence intervals (95% CI) for cross-sectional associations between both ambient and blood styrene levels and self-reported neurologic symptoms. We estimated associations independently for ten unique symptoms, as well as for the presence of any neurologic, central nervous system (CNS), or peripheral nervous system (PNS) symptoms. We also examined heterogeneity of associations with estimated ambient styrene levels by race and sex.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P3">One-third of participants reported at least one neurologic symptom. The highest quartile of estimated ambient styrene was associated with one or more neurologic (PR, 1.12; 95% CI: 1.07,1.18), CNS (PR, 1.17; 95% CI: 1.11,1.25), and PNS (PR, 1.16; 95% CI: 1.09,1.25) symptom. Results were less consistent for biomarker analyses, but blood styrene level was suggestively associated with nausea (PR, 1.78; 95% CI: 1.04, 3.03). In stratified analyses, we observed the strongest effects among non-White participants.</p>
</sec>
<sec id="S4">
<title>Conclusions:</title>
<p id="P4">Increasing estimated ambient styrene concentration was consistently associated with increased prevalence of neurologic symptoms. Associations between blood styrene levels and some neurologic symptoms were suggestive. Environmental styrene exposure levels may be sufficient to elicit symptomatic neurotoxic effects.</p>
</sec>
</abstract>
<kwd-group>
<kwd>air pollution</kwd>
<kwd>nervous system</kwd>
<kwd>styrene</kwd>
<kwd>biomarker</kwd>
<kwd>neurologic</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>